Vivani Medical
VANI
29 hedge funds and large institutions have $5.52M invested in Vivani Medical in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 7 closing their positions.
650% more call options, than puts
Call options by funds: $15K | Put options by funds: $2K
6% more capital invested
Capital invested by funds: $5.23M → $5.52M (+$294K)
0.23% less ownership
Funds ownership: 6.84% → 6.61% (-0.23%)
9% less funds holding
Funds holding: 32 → 29 (-3)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$60.8K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$24.9K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$22K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$21K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.19K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$123K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$121K |
| 3 |
Jane Street
New York
|
-$22.7K |
| 4 |
Goldman Sachs
New York
|
-$18.6K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$14.3K |
VANI Hedge Fund Activity: Q3 2025 in Review
29 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q3 2025, worth a combined $5.52M — up 5.6% from $5.23M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of VANI and 4 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 4 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $60.8K. The largest seller was Vanguard Group, cutting an estimated $123K.
- 29 institutional investors held Vivani Medical (VANI) as of Q3 2025, down from 32 in Q2 2025.
- Funds reported $5.52M of Vivani Medical stock for Q3 2025, up 5.6% quarter-over-quarter.
- 4 funds opened new Vivani Medical positions in Q3 2025 and 7 closed out, a net change of -3 holders.
- The largest Vivani Medical buyer in Q3 2025 was Renaissance Technologies, an estimated $60.8K added.
- The largest Vivani Medical seller in Q3 2025 was Vanguard Group, an estimated $123K sold.
Based on aggregated 13F filings for Q3 2025.